Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-09-000147
Filing Date
2009-04-01
Accepted
2009-04-01 17:02:23
Documents
1
Period of Report
2009-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3927
  Complete submission text file 0000908662-09-000147.txt   5809
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address
COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 09724196
SIC: 2836 Biological Products, (No Diagnostic Substances)